Location History:
- Cambridge, GB (2022 - 2024)
- Milton Keynes, GB (2024)
Company Filing History:
Years Active: 2022-2024
Title: Franck Rubiconi: Innovator in Inhaler Technology
Introduction
Franck Rubiconi is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of inhaler technology, holding a total of 5 patents. His innovative designs focus on enhancing the efficiency and functionality of inhalation devices.
Latest Patents
Rubiconi's latest patents include advanced inhaler designs that utilize piezoelectric elements for atomization. One of his patents describes an inhaler that features an atomizing unit with a piezoelectric element substrate. This substrate includes a first interdigitated transducer (IDT) with interlocking comb-shaped electrodes. The atomizing unit is designed to atomize liquid through a surface acoustic wave generated by applying a high-frequency voltage to these electrodes. Additionally, a controller monitors the resonant frequency of the electrodes and adjusts the voltage accordingly. Another patent outlines a controller for an atomizing unit that also employs a piezoelectric element substrate. This design allows for periodic changes in amplitude and frequency of the high-frequency voltage applied to the electrodes, further optimizing the atomization process.
Career Highlights
Throughout his career, Franck Rubiconi has worked with prominent companies such as Japan Tobacco Inc. and Novartis AG. His experience in these organizations has contributed to his expertise in developing innovative inhalation technologies.
Collaborations
Rubiconi has collaborated with talented individuals in the field, including Yuki Minami and Takahisa Kudo. These partnerships have fostered a creative environment that has led to the development of groundbreaking inhaler technologies.
Conclusion
Franck Rubiconi's contributions to inhaler technology demonstrate his commitment to innovation and improvement in healthcare devices. His patents reflect a deep understanding of the mechanics involved in atomization, paving the way for more effective inhalation therapies.